Medicago Inc. (MDG.V) announced additional positive results for its H5N1 Avian Influenza VLP vaccine from a pre-clinical immunogenicity study performed in ferrets. The results of the study showed that H5N1 VLP vaccine induced antibodies that neutralized strains of H5N1 circulating virus beyond the strain used to develop the original vaccine. The study demonstrated cross-reactivity against three deadliest strains of H5N1, namely Turkey strain, Anhui strain, and Vietnam strain.
The company said the objective of pre-clinical immunogenicity study was to evaluate the optimal dosage of H5N1 VLP vaccine in ferrets, the most predictive animal model used for the purpose.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.